INVESTMENTS AND FAIR VALUE DISCLOSURES (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Components of the Company's Investments |
The following table presents the components of the Company’s investments: | | | | | | | | | | | | | (dollars in thousands) | June 30, 2026 | | December 31, 2025 | | Preferred equity investment, at fair value | $ | 310,171 | | | $ | 290,594 | | | Equity investments in the Company’s products, equity method | 79,482 | | | 67,391 | | Loans and deferred purchase price receivable, at amortized cost (includes $29,431 and $27,797 in the Company’s products, respectively) | 60,850 | | | 58,845 | | Equity investments in the Company’s products, at fair value | 108,545 | | | 61,906 | | | Investments in the Company’s CLOs, at fair value | 4,623 | | | 5,653 | | | | | | | Total | $ | 563,671 | | | $ | 484,389 | |
|
| Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
The tables below summarize the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | (dollars in thousands) | | Level I | | Level II | | Level III | | Total | | | | | | | | | | | | | | | | | | | | Cash Equivalents, at Fair Value | | | | | | | | | | Money market funds | | $ | 55,406 | | | $ | — | | | $ | — | | | $ | 55,406 | | | Investments, at Fair Value | | | | | | | | | | Preferred equity investment | | — | | | — | | | 310,171 | | | 310,171 | | | Equity investments in the Company’s products | | — | | | 108,545 | | | — | | | 108,545 | | | CLOs | | — | | | — | | | 4,623 | | | 4,623 | | | Total Investments, at Fair Value | | $ | — | | | $ | 108,545 | | | $ | 314,794 | | | $ | 423,339 | | | Total Assets, at Fair Value | | $ | 55,406 | | | $ | 108,545 | | | $ | 314,794 | | | $ | 478,745 | | | | | | | | | | | | Liabilities, at Fair Value | | | | | | | | | | TRA liability | | $ | — | | | $ | — | | | $ | 98,659 | | | $ | 98,659 | | | | | | | | | | | | Earnout liability | | — | | | — | | | 93,700 | | | 93,700 | | | Total Liabilities, at Fair Value | | $ | — | | | $ | — | | | $ | 192,359 | | | $ | 192,359 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | (dollars in thousands) | | Level I | | Level II | | Level III | | Total | | Investments, at Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | Preferred equity investment | | $ | — | | | $ | — | | | $ | 290,594 | | | $ | 290,594 | | | Equity investments in the Company’s products | | — | | | 61,906 | | | — | | | 61,906 | | | CLOs | | — | | | — | | | 5,653 | | | 5,653 | | | Total Assets, at Fair Value | | $ | — | | | $ | 61,906 | | | $ | 296,247 | | | $ | 358,153 | | | | | | | | | | | | Liabilities, at Fair Value | | | | | | | | | | TRA liability | | $ | — | | | $ | — | | | $ | 106,793 | | | $ | 106,793 | | | | | | | | | | | | Earnout liability | | — | | | — | | | 163,700 | | | 163,700 | | | Total Liabilities, at Fair Value | | $ | — | | | $ | — | | | $ | 270,493 | | | $ | 270,493 | |
|
| Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation |
The following table sets forth a summary of changes in the fair value of the Level III measurements for the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | Level III Assets | | (dollars in thousands) | Preferred Equity | | CLOs | | Total | | Beginning balance | $ | 303,685 | | | $ | 4,375 | | | $ | 308,060 | | Purchases(1) | 9,475 | | | — | | | 9,475 | | | Net gains (losses) | (2,989) | | | 248 | | | (2,741) | | | Ending Balance | $ | 310,171 | | | $ | 4,623 | | | $ | 314,794 | | | Change in net unrealized gains (losses) on assets still recognized at the reporting date | $ | (2,989) | | | $ | 248 | | | $ | (2,741) | | | | | | | | | Six Months Ended June 30, 2026 | Level III Assets | | (dollars in thousands) | Preferred Equity | | CLOs | | Total | | Beginning balance | $ | 290,594 | | | $ | 5,653 | | | $ | 296,247 | | Purchases(1) | 18,571 | | | — | | | 18,571 | | | Net gains (losses) | 1,006 | | | (1,030) | | | (24) | | | Ending Balance | $ | 310,171 | | | $ | 4,623 | | | $ | 314,794 | | | Change in net unrealized gains (losses) on assets still recognized at the reporting date | $ | 1,006 | | | $ | (1,030) | | | $ | (24) | |
(1)Preferred equity purchases includes $9.5 million and $18.6 million respectively, of cumulative unpaid cash preferential dividends that compound quarterly and are payable when declared. | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | Level III Assets | | (dollars in thousands) | Preferred Equity | | CLOs | | Total | | Beginning balance | $ | 268,263 | | | $ | 7,701 | | | $ | 275,964 | | Purchases(1) | 8,418 | | | — | | | 8,418 | | | Net losses | (4,051) | | | (829) | | | (4,880) | | | Ending Balance | $ | 272,630 | | | $ | 6,872 | | | $ | 279,502 | | | Change in net unrealized losses on assets still recognized at the reporting date | $ | (4,051) | | | $ | (829) | | | $ | (4,880) | | | | | | | | | Six Months Ended June 30, 2025 | Level III Assets | | (dollars in thousands) | Preferred Equity | | CLOs | | Total | | Beginning balance | $ | 267,169 | | | $ | 5,169 | | | $ | 272,338 | | Purchases(1) | 16,499 | | | 3,986 | | | 20,485 | | | Net losses | (11,038) | | | (2,283) | | | (13,321) | | | Ending Balance | $ | 272,630 | | | $ | 6,872 | | | $ | 279,502 | | | Change in net unrealized losses on assets still recognized at the reporting date | $ | (11,038) | | | $ | (2,283) | | | $ | (13,321) | |
(1)Preferred equity purchases includes $8.4 million and $16.5 million respectively, of cumulative unpaid cash preferential dividends that compound quarterly and are payable when declared.
|
| Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation |
| | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | Level III Liabilities | | (dollars in thousands) | TRA Liability | | Earnout Liability | | Total | | Beginning balance | $ | 95,748 | | | $ | 147,600 | | | $ | 243,348 | | | Issuances | — | | | — | | | — | | | | | | | | | Settlements | — | | | (59,909) | | | (59,909) | | | Net losses | 2,911 | | | 6,009 | | | 8,920 | | | Ending Balance | $ | 98,659 | | | $ | 93,700 | | | $ | 192,359 | | | Change in net unrealized losses on liabilities still recognized at the reporting date | $ | 2,911 | | | $ | 6,009 | | | $ | 8,920 | | | | | | | | | Six Months Ended June 30, 2026 | Level III Liabilities | | (dollars in thousands) | TRA Liability | | Earnout Liability | | Total | | Beginning balance | $ | 106,793 | | | $ | 163,700 | | | $ | 270,493 | | | Issuances | — | | | — | | | — | | | | | | | | | Settlements | (14,100) | | | (59,909) | | | (74,009) | | | Net (gains) losses | 5,966 | | | (10,091) | | | (4,125) | | | Ending Balance | $ | 98,659 | | | $ | 93,700 | | | $ | 192,359 | | | Change in net unrealized (gains) losses on liabilities still recognized at the reporting date | $ | 5,966 | | | $ | (10,091) | | | $ | (4,125) | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | Level III Liabilities | | (dollars in thousands) | TRA Liability | | | | Earnout Liability | | Total | | Beginning balance | $ | 97,228 | | | | | $ | 305,680 | | | $ | 402,908 | | | | | | | | | | | Settlements | — | | | | | (113,350) | | | (113,350) | | | Net (gains) losses | 2,274 | | | | | (20,632) | | | (18,358) | | | Ending Balance | $ | 99,502 | | | | | $ | 171,698 | | | $ | 271,200 | | | Change in net unrealized (gains) losses on liabilities still recognized at the reporting date | $ | 2,274 | | | | | $ | (8,666) | | | $ | (6,392) | | | | | | | | | | | Six Months Ended June 30, 2025 | Level III Liabilities | | (dollars in thousands) | TRA Liability | | | | Earnout Liability | | Total | | Beginning balance | $ | 108,257 | | | | | $ | 167,912 | | | $ | 276,169 | | | Issuances | — | | | | | 140,083 | | | 140,083 | | | Settlements | (14,556) | | | | | (113,350) | | | (127,906) | | | Net (gains) losses | 5,801 | | | | | (22,947) | | | (17,146) | | | Ending Balance | $ | 99,502 | | | | | $ | 171,698 | | | $ | 271,200 | | | Change in net unrealized losses on liabilities still recognized at the reporting date | $ | 5,801 | | | | | $ | 8,698 | | | $ | 14,499 | |
|
| Schedule of Fair Value Measurement Inputs and Valuation Techniques |
The following table summarizes the quantitative inputs and assumptions used for the Company’s Level III measurements as of June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (dollars in thousands) | | Fair Value | | Valuation Technique | | Significant Unobservable Inputs | | Range | | Weighted Average | | Impact to Valuation from an Increase in Input | | Assets | | | | | | | | | | | | | | | | Preferred equity | | $ | 310,171 | | | Discounted cash flow | | Discount Rate | | 14 | % | - | 14% | | 14 | % | | Decrease | | CLOs | | 4,623 | | | Discounted cash flow | | Yield | | 11 | % | - | 15% | | 12 | % | | Decrease | | Total Assets, at Fair Value | | $ | 314,794 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | | TRA liability | | $ | 98,659 | | | Discounted cash flow | | Discount Rate | | 13 | % | - | 13% | | 13 | % | | Decrease | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Earnout liability | | 93,700 | | | Monte Carlo Simulation | | Volatility | | 23 | % | - | 27% | | 24 | % | | Decrease | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Liabilities, at Fair Value | | $ | 192,359 | | | | | | | | | | | | | |
The following table summarizes the quantitative inputs and assumptions used for the Company’s Level III measurements as of December 31, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (dollars in thousands) | | Fair Value | | Valuation Technique | | Significant Unobservable Inputs | | Range | | Weighted Average | | Impact to Valuation from an Increase in Input | | Assets | | | | | | | | | | | | | | | | Preferred equity | | $ | 290,594 | | | Discounted cash flow | | Discount Rate | | 14 | % | - | 14% | | 14 | % | | Decrease | | CLOs | | 5,653 | | | Discounted cash flow | | Yield | | 10 | % | - | 14% | | 12 | % | | Decrease | | Total Assets, at Fair Value | | $ | 296,247 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | | TRA liability | | $ | 106,793 | | | Discounted cash flow | | Discount Rate | | 13 | % | - | 13% | | 13 | % | | Decrease | | | | | | | | | | | | | | | | | Earnout liability | | 163,700 | | | Monte Carlo Simulation | | Volatility | | 21 | % | - | 24% | | 22 | % | | Increase | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total Liabilities, at Fair Value | | $ | 270,493 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|